S&R Associates represented Glenmark Pharmaceuticals Limited, a listed pharmaceutical company, and an affiliate in the INR 7.98 billion sale of 7.85% of the equity shares of Glenmark Life Sciences Limited, a listed active pharmaceutical ingredients manufacturer, pursuant to an offer for sale on the BSE and the NSE.
The S&R team was led by partners Rajat Sethi and Pratichi Mishra, and included associates Samyak Jain and Oshika Nayak.
For reference, please see the stock exchange announcements below in relation to the transaction:
https://www.bseindia.com/xml-data/corpfiling/AttachHis/38da4a26-16e6-466b-95e7-157ca4d984ca.pdf
https://nsearchives.nseindia.com/corporate/GLS_16072024172148_Disclosure_MPS_16072024_Signed.pdf